News

Biocon eyes early lead in generic Wegovy, Ozempic sales in Canada from 2026
The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...
India’s Biocon aims to lead copycat Wegovy sales in Canada from next year
The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...
Biocon aims to lead copycat Wegovy sales in Canada from next year
Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...
Biocon climbs 3% on plans to file approvals for generic weight-loss drug
Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of ...
Biocon eyes Canadian bonanza from generics of weight-loss 'super-drugs' Ozempic and Wegovy
Biocon Ltd. is set to seek regulatory approvals for generic versions of Novo Nordisk's Ozempic and Wegovy, targeting key ...
Semaglutide Market Forecast Report 2025-2033 Growth Accelerates Amid Rising Awareness, Regulatory Approvals, And Strong Pipeline Advancements
The Semaglutide market is projected to expand from US$ 27.15 billion in 2024 to US$ 61.7 billion by 2033, with a CAGR of 9.55% from 2025. Driven by r ...